Back to results
US 12,730,114 B2Granted
Method for classifying an allergic patient as eligible to allergen immunotherapy
AssigneeStallergenes Greer International AG
InventorGiampiero De Luca
Life of this patent
Estimating the term…
Abstract
Disclosed is a method of improving global response to allergen desensitization, by allergen immunotherapy, which includes classifying allergic patients as eligible to allergen immunotherapy based on the patients' allergen-specific T cell reactivity against the allergen.
Claims18
A method of treating a patient allergic to an antigen comprising:
- (i) classifying said allergic patient as eligible to allergen immunotherapy, said method comprising screening the T cell reactivity of said patient to an allergen, said screening comprising the following steps:
- a) contacting with an allergen an isolated biological sample of the patient containing T cells,
- b) measuring T cell reactivity to said allergen,
- c) calculating a stimulation index as the ratio of the T cell reactivity measured in step b) on T cell reactivity of the isolated biological sample of the patient containing T cells unstimulated by the allergen,
- d) classifying said patient as being eligible to treatment with a composition comprising said allergen if the stimulation index is equal or above a threshold value;
- and
- (iia) administering to the patient a composition comprising the allergen if the patient is classified as being eligible to treatment with a composition comprising said allergen, and
- (iib) if the patient is not classified as eligible to treatment with a composition comprising said allergen:
- a) determining the patient's sensitivity to individual allergenic proteins of the allergen;
- b) spiking the allergen with the allergenic protein(s) to which the patient is sensitized;
- and
- c) administering to the patient the spiked allergen.
9 more elements
Dependencies are inferred from the claim text.